Deseret News (Salt Lake City) - Vytorin-cancer link can't be ruled out, doctors say
Monday, November 3rd, 2008 MUNICH, Germany — Results so far from three studies of the cholesterol-lowering drug Vytorin are not enough to prove or rule out a possible link to a higher risk of cancer, so the drug should be used with caution until more is known, editors of a leading medical journal urged Tuesday.
The New England Journal of Medicine published results online from one study and an analysis of partial results from two oth…
